Nektar Therapeutics Announces Public Offering

Nektar Therapeutics NKTR today announced that it is offering to sell shares of its common stock in a firm commitment underwritten public offering. Jefferies & Company, Inc. is acting as sole book-running manager in this offering. The public offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.